Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Steve Lombardi, Nicole DeBerg, Andrea Califano, Arnold Levine, Aviv Regev, More


Nabsys has appointed Steve Lombardi to president, CEO, and to its board of directors. Previously, he was CEO of Real Time Genomics, and before that, he was CEO of Helicos BioSciences. He has also served as senior vice president of Affymetrix and vice president of genetic analysis at Applied Biosystems.

The J. Craig Venter Institute has hired Nicole DeBerg as chief operating officer. Previously, she was CFO and vice president of financial services at the San Diego Housing Commission. Prior to that, she held financial leadership positions at several emerging biotechnology companies, including Altair Therapeutics, Kalypsys, and Depotech. She was also CFO at the Sanford-Burnham Medical Research Institute.

Thermo Fisher Scientific has appointed Andrea Califano, Arnold Levine, and Aviv Regev to its scientific advisory board.

Califano is founding chairman of the department of systems biology at Columbia University and he currently serves on th board of scientific advisors at the National Cancer Institute.

Levine is professor emeritus of systems biology at the Institute for Advanced Study and professor of pediatrics and of biochemistry with the Robert Wood Johnson Medical School at Rutgers, the State University of New Jersey.

Regev is a core member of the Broad Institute and an associate professor of biology at the Massachusetts Institute of Technology. She is also an investigator at the Howard Hughes Medical Institute.

Agilent has appointed Alessandro Borsatti to senior director of product marketing and scientific affairs. He has had various roles at Agilent since joining the company in February 2013. Before that, he was global business director of molecular diagnostics at PerkinElmer. Agilent has also appointed Rebecca Brandes to global marketing director of molecular pathology. She is a co-founder of Prairie Fire Labs and was also the owner and executive vice president of sales and marketing at i.d.i consulting and Celerity Marketing Group.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.